Lizomac DS Dry Syrup

Description

Introduction

In Treatment of Resistant Tuberculosis (TB) In multidrug-resistant (MDR) tuberculosis, the causative bacteria produce an enzyme that makes the antibiotics ineffective. As a result, the bacteria become resistant to the antibiotic being used for treatment. Lizomac DS Dry Syrup is effective in treating MDR tuberculosis and Extensively Drug-resistant tuberculosis (XDR-TB). Lizomac DS Dry Syrup is not the first medicine that the doctor gives to treat tuberculosis. It is given only if the child suffers from resistant-tubercular infection. In Treatment of Severe bacterial infections Lizomac DS Dry Syrup works by killing bacteria which can cause serious infections. It is used to treat many different types of bacterial infections such as infections of lungs (pneumonia), skin, and soft tissues. This medicine usually makes you feel better very quickly but you should continue taking it as prescribed even when you feel better to make sure that all bacteria are killed and do not become resistant.

Benefits

Lizomac DS Dry Syrup is an antibiotic. It stops bacterial growth by preventing the synthesis of essential proteins required by bacteria to carry out vital functions.

How to use

Safety Advice

- Kidney : SAFE IF PRESCRIBED - Lizomac DS Dry Syrup is safe to use in patients with kidney disease. No dose adjustment of Lizomac DS Dry Syrup is recommended. However, Lizomac DS Dry Syrup must be used with caution in children with severe kidney disease. Dose modification may be required in severe kidney disease. - Liver : SAFE IF PRESCRIBED - Lizomac DS Dry Syrup is safe to use in patients with liver disease. No dose adjustment of Lizomac DS Dry Syrup is recommended. However, Lizomac DS Dry Syrup should be used with caution in children with severe liver disease as it can be a potential threat to liver functions although not very common.